What is the recommended A1C goal for a 92-year-old patient with type 2 diabetes (T2D), who is wheelchair-bound and dependent for all activities of daily living (ADLs), according to the American Diabetes Association (ADA) Standards of Care?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For SD, a 92-year-old with type 2 diabetes who is wheelchair-bound and dependent for all ADLs, I recommend an A1C goal of < 8 to 8.5%. This less stringent glycemic target is appropriate given SD's advanced age, significant functional limitations, and complex insulin regimen, as supported by the American Diabetes Association Standards of Care 1. The ADA Standards of Care specifically recommends less strict glycemic control for older adults with multiple comorbidities, limited life expectancy, and functional dependence, citing the importance of avoiding hypoglycemia and maintaining cognitive and functional status 1. With SD's current intensive medication regimen (insulin glargine 28 units daily, insulin lispro 8 units pre-meals, metformin 500 mg BID, and glipizide 10 mg BID), the risk of hypoglycemia is substantial, and targeting a higher A1C range helps balance diabetes management while minimizing the dangerous consequences of hypoglycemia, which can be particularly harmful in frail elderly patients 1. Key considerations for SD's care include:

  • Avoiding hypoglycemia and symptomatic hyperglycemia to provide comfort and avoid tasks or interventions that cause pain or discomfort 1
  • Simplifying SD's medication regimen to reduce hypoglycemia risk while maintaining reasonable glycemic control within the target range 1
  • Regularly assessing SD's cognitive and functional status to adjust the treatment plan as needed 1
  • Considering deintensification or deprescribing of medications if they are no longer providing a clear benefit or are causing undue burden on SD or their caregivers 1.

From the Research

Patient Profile

  • SD is a 92-year-old patient with a history of type 2 diabetes.
  • The patient is wheelchair-bound and impaired or dependent for all Activities of Daily Living (ADLs).
  • Current medications for diabetes include insulin glargine, insulin lispro, metformin, and glipizide.

A1C Goal Recommendation

  • According to the American Diabetes Association (ADA) Standards of Care, the recommended A1C goal for older adults with diabetes, such as SD, is less stringent than for younger adults 2, 3.
  • Considering SD's age, disability, and comorbidities, a less stringent A1C goal may be appropriate to minimize the risk of hypoglycemia and other adverse effects.
  • The ADA recommends an A1C goal of < 8% for older adults with diabetes, but this can be individualized based on the patient's health status and preferences 3.
  • Based on the available evidence, a reasonable A1C goal for SD could be < 8 to 8.5% 2, 3.

Rationale

  • The studies suggest that older adults with diabetes, such as SD, may require a more relaxed A1C goal due to the increased risk of hypoglycemia and other complications 2, 3.
  • The use of metformin in patients over 80 years of age should be avoided due to declining kidney function 2.
  • Insulin therapy is an option, but patients should be monitored carefully for the development of hypoglycemia 2.
  • The choice of insulin regimen, such as insulin lispro mixture or insulin glargine, can affect glycemic control and hypoglycemia risk 4, 5, 6.

Related Questions

What is the best course of action for a patient with hyperglycemia, who was administered 14 units of lispro (Humalog) and 10 units of glargine (Lantus), and remains noncompliant with dietary recommendations despite normal vital signs?
What is the required observation period for a patient who accidentally took 17 units of Humalog (insulin lispro) instead of Lantus (insulin glargine) to ensure no hypoglycemia?
What is the recommended insulin regimen for a patient with uncontrolled diabetes and significant obesity, specifically regarding the use of basal insulin (e.g. glargine (insulin glargine)) and short-acting insulin (e.g. aspart (insulin aspart) or lispro (insulin lispro))?
What are the monitoring parameters for a patient on Farxiga (dapagliflozin), Metformin, Lantus (insulin glargine) and insulin lispro?
What is the appropriate management for a 55-year-old male patient with persistent hyperglycemia, taking Glipizide (glyburide) 5mg twice daily (BID) and Semglee (insulin glargine) 10 units once daily (QD), with blood glucose levels ranging from 300 to 500 mg/dL, including two readings above 500 mg/dL, measured daily at noon?
What is the treatment for hydroxyurea (Hydrea)-induced leg ulcers?
What is the appropriate management for a patient with atrial fibrillation (Afib) and an International Normalized Ratio (INR) of 1.6 while taking 4mg of Coumadin (warfarin) daily?
What is the recommended A1C (Glycated Hemoglobin) goal for a healthy 82-year-old adult with a new diagnosis of diabetes mellitus and an initial A1C level of 8.3%, according to the American Diabetes Association (ADA) Standards of Care?
What factors predict life expectancy in a 92-year-old patient with type 2 diabetes (T2D), including duration of diabetes, reliance on a wheelchair, need for nursing home care/long-term care, and polypharmacy with medications such as insulin glargine (insulin glargine), insulin lispro (insulin lispro), metformin (metformin), and glipizide (glipizide)?
What component of BJ's past medical history (PMH) might be a concern when initiating metformin (a biguanide oral hypoglycemic agent) therapy, given his history of lower extremity edema, macrocytic anemia due to vitamin B12 deficiency, fungal skin infections, and osteopenia, with an elevated Hemoglobin A1C (HbA1C) level indicating hyperglycemia?
What tool would provide a recommended list of medications to avoid in a 72-year-old patient with a history of lower extremity edema, macrocytic anemia due to vitamin B12 deficiency, fungal skin infections, and osteopenia, and an elevated Hemoglobin A1C (HbA1C) level, currently residing in a long-term care facility?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.